Intra-Cellular Therapies, Inc. (ITCI)
- GlobeNewswire
Intra-Cellular Therapies to Present at the 2023 Cantor Fitzgerald Global Healthcare Conference
NEW YORK, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that it will present at the 2023 Cantor Fitzgerald Global Healthcare Conference on Wednesday, September 27, 2023 at 1:15 p.m. ET. The live and archived webcast can be accessed under "Events & Presentations" in the Investor Relations section of the Company
- GuruFocus.com
Insider Sell: Sharon Mates Sells 100,000 Shares of Intra-Cellular Therapies Inc
On September 19, 2023, Sharon Mates, Chairman, President & CEO of Intra-Cellular Therapies Inc (NASDAQ:ITCI), sold 100,000 shares of the company.
- Simply Wall St.
Loss-Making Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Expected To Breakeven In The Medium-Term
Intra-Cellular Therapies, Inc. ( NASDAQ:ITCI ) is possibly approaching a major achievement in its business, so we would...
